vimarsana.com

Latest Breaking News On - Guangzhou jinkong fund - Page 1 : vimarsana.com

Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials

/PRNewswire/ Neurophth Therapeutics, Inc. ("Neurophth"), a China s leading gene therapy company for ophthalmic diseases, announced the closing of nearly 95.

Hsu zhangMacau generalChina generalYangtze riverHuang chengEric linGuangdong hong kongEuropean medicines agencyGuangzhou jinkong fundDonghu new technology development zoneInternational industry fundChina merchant bank international capitalTech holding groupWuhan optical valley financial holding groupAngel fundYangtze river industry fund

Neurophth Raises Nearly USD95M in Series C+ Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

China generalYangtze riverWuhan optical valley financial holding groupEuropean medicines agencyInternational industry fundTech holding groupGuangzhou jinkong fundAngel fundChina merchant bank international capitalOriza holdingsYangtze river industry fundNeurophth therapeuticsIndustry fundWuhan hi tech holding groupGuangzhou jinkongSilicon paradise asset management

vimarsana © 2020. All Rights Reserved.